Page 1 | Search Results | Blood | American Society of Hematology

1-18 of 18

Sort by

Sort Order Select

Journal Articles

Lymphocyte Recovery Kinetics in Patients Undergoing Myeloablative Conditioning and Allogeneic Stem Cell Transplantation

David Jared Kobulnicky, MD, Roy T Sabo, PhD, Ali S Shubar Ali, BS, Catherine H. Roberts, PhD, Allison F Scalora, MS, Kristen M Kobulnicky, MS, Shiyu Song, MDPhD, William B. Clark, MD, Harold M. Chung, MD, John M. McCarty, MD, Michael C. Neale, PhD, Amir A. Toor, MD

Blood (2015) 126 (23): 5467.

https://doi.org/10.1182/blood.V126.23.5467.5467

Published: 2015

Journal Articles

The Use of Biomarker Ferritin and Albumin As Well As HCT-CI, but Not PAM, Was Predictive of Suvival, Gvhd and, Relapse in Myeloid Malignancies

Gary Simmons, DO, Allison F. Scalora, MS, Roy T Sabo, PhD, Catherine H. Roberts, PhD, William B. Clark, MD, Harold M. Chung, MD, Amir A. Toor, MD, John M. McCarty, MD

Blood (2015) 126 (23): 5448.

https://doi.org/10.1182/blood.V126.23.5448.5448

Published: 2015

Journal Articles

A Mathematical Model of Hematopoietic Stem Cell Transplantation and Analysis of the Effect of Drug Treatments on Transplantation in Patients with Lymphoma

Racheal L Cooper, MS, Allison F. Scalora, MS, Elaine Wang, MD, John M. McCarty, MD, Jennifer Anderson, RN, Catherine H. Roberts, PhD, Troy Lund, MD PhD, Amir A. Toor, MD, Angela Reynolds, PhD

Blood (2015) 126 (23): 2376.

https://doi.org/10.1182/blood.V126.23.2376.2376

Published: 2015

Journal Articles

Peptides Derived from the CMV Proteome Mimic Unique Stem Cell Transplant Recipient Specific Peptides: Possible Role in Eliciting a Pro-Gvh T Cell Response

Charles E. Hall, MS, Max Jameson-Lee, PhD, Abdelrhman Elnasseh, Vishal Koparde, PhD, Allison F. Scalora, MS, Catherine H. Roberts, PhD, Nihar U. Sheth, MS, Myrna G. Serrano, PhD, Daniel Nixon, DO, PhD, Harold M. Chung, MD, Oveimar A. De la Cruz, MD, William B. Clark, MD, John M. McCarty, MD, Gregory A. Buck, PhD, Michael C. Neale, PhD, Amir A. Toor, MD

Blood (2015) 126 (23): 4285.

https://doi.org/10.1182/blood.V126.23.4285.4285

Published: 2015

Journal Articles

Exome Sequencing Derived Alloreactivity Potential May Predict Gvhd in Allogeneic Stem Cell Transplantation

Max Jameson-Lee, PhD, Allison F Scalora, MS, Vishal Koparde, PhD, David Jared Kobulnicky, MD, Badar Abdur Razzaq, BS, Andrea Ferreira-Gonzalez, PhD, Myrna G. Serrano, PhD, Catherine H. Roberts, PhD, Gregory Buck, PhD, Michael C. Neale, PhD, Amir A. Toor, MD

Blood (2015) 126 (23): 3078.

https://doi.org/10.1182/blood.V126.23.3078.3078

Published: 2015

Journal Articles

On The Organization Of Human T Cell Receptor Loci

Abdullah A Toor, Amir A Toor, MD

Blood (2013) 122 (21): 2292.

https://doi.org/10.1182/blood.V122.21.2292.2292

Published: 2013

Journal Articles

Whole Exome Sequencing To Estimate Alloreactivity Potential Between Donors and Recipients In Stem Cell Transplantation

Juliana Sampson, PhD, Nihar Sheth, PhD, Vishal N Koparde, PhD, Allison Scalora, MS, Myrna G Serrano, PhD, Vladimir Lee, PhD, Maximillian Jamison-Lee, PhD, Andrea Ferreira-Gonzalez, PhD, Catherine H Roberts, PhD, Masoud H Manjili, DVM, PhD, Gregory Buck, PhD, Michael C Neale, PhD, Amir A Toor MD

Blood (2013) 122 (21): 150.

https://doi.org/10.1182/blood.V122.21.150.150

Published: 2013

Journal Articles

Favorable T Cell Reconstitution In Reduced Intensity Conditioned Allogeneic Stem Cell Transplantation with Low-Dose Rabbit Anti-Thymocyte Globulin and Total Body Irradiation

Radhika Thorn, MD, Jeremy Meier, BS, Elaine Wang, MD, Roy T Sabo, PhD, Allison F Scalora, MS, Catherine H Roberts, PhD, Shiyu Song, MD, PhD, Masoud H Manjili, DVM, PhD, William B Clark, MD, John M McCarty, MD, Harold M Chung, MD, Amir A Toor, MD

Blood (2013) 122 (21): 4577.

https://doi.org/10.1182/blood.V122.21.4577.4577

Published: 2013

Journal Articles

Immune Reconstitution In Anti-Thymocyte Globulin Conditioned Unrelated Donor Stem Cell Transplantation

David Jared Kobulnicky, MD, Roy T Sabo, PhD, Allison F Scalora, MS, David Portier, MD, Devon Fletcher, MD, Jeffrey M Tessier, MD, William B Clark, MD, Harold M Chung, MD, John M McCarty, MD, Catherine H Roberts, PhD, Amir A Toor, MD

Blood (2013) 122 (21): 2071.

https://doi.org/10.1182/blood.V122.21.2071.2071

Published: 2013

Journal Articles

Optimizing Outcomes in Multiple Myeloma Using Risk Stratified Allocation to Single Versus Tandem Autologous SCT.

Matthew Risendal, BS, Roy T Sabo, PhD, Allison F Hazlett, MS, Priscilla Mpasi, BS, Joan Bolling, William B Clark, MD, John M McCarty, MD, Harold M Chung, MD, Catherine H Roberts, PhD, Amir A Toor, MD

Blood (2012) 120 (21): 3123.

https://doi.org/10.1182/blood.V120.21.3123.3123

Published: 2012

Journal Articles

Fractal Organization of the Human T Cell Repertoire in Health and Following Stem Cell Transplantation

Jeremy Meier, Allison F Hazlett, MS, Kassi Avent, MS, Jennifer Berrie, Kyle Payne, David Hamm, MS, Cindy Desmarais, PhD, Catherine Sanders, PhD, Kevin T Hogan, PhD, Steven Grant, MD, Kellie J Archer, PhD, Masoud H Manjili, DVM, PhD, Catherine Roberts, PhD, Amir A Toor, MD

Blood (2012) 120 (21): 4193.

https://doi.org/10.1182/blood.V120.21.4193.4193

Published: 2012

Journal Articles

Favorable Outcomes in Patients with High Donor-Derived T Cell Count Following In Vivo T Cell Depleted Reduced Intensity Allogeneic Stem Cell Transplantation

Amir A Toor, MD, Roy T Sabo, PhD, Harold M Chung, MD, Catherine H Roberts, PhD, Rose H Manjili, BS, Shiyu Song, MD, PhD, David C. Williams, Jr., MD, PhD, William Clark, MD, Masoud H Manjili, DVM, PhD, John M McCarty, MD

Blood (2011) 118 (21): 3043.

https://doi.org/10.1182/blood.V118.21.3043.3043

Published: 2011

Journal Articles

Adaptive Immunotherapy In Multiple Myeloma: Epigenetic Modification and Immunomodulation by Sequential Azacitidine and Lenalidomide to Generate Cancer Testis Antigen Specific Cellular Immune Response

Amir A Toor, MD, Kyle Payne, BS, Harold M Chung, MD, Catherine H Roberts, PhD, Roy T Sabo, PhD, Maciej Kmieciak, PhD, William Clark, MD, Christy McLaughlin, BS, Angela Buskey, RN, Jennifer Anderson, RN, Rose H Manjili, BS, Susan D. Roseff, MD, John M McCarty, MD, Masoud H Manjili, DVM, PhD

Blood (2011) 118 (21): 2926.

https://doi.org/10.1182/blood.V118.21.2926.2926

Published: 2011

Journal Articles

Effectiveness of Reduced Toxicity Conditioning Regimen with Intravenous Busulfan Plus Pentostatin (BUPENT) in Patients Older Than 50 Years with Advanced Hematologic Malignancies.

Tulio E. Rodriguez, MD, Mala Parthasarathy, MS, Scott E. Smith, MD, PhD, David H. Vesole, MD, PhD, Zachary M. Earley, Aaron T. Gerds, MD, Amir A. Toor, MD, Patrick J. Stiff, MD

Blood (2009) 114 (22): 3331.

https://doi.org/10.1182/blood.V114.22.3331.3331

Published: 2009

Journal Articles

Refractory Thrombocytopenia Due to Allo-Immune Anti-CD36 Complicating Unrelated Donor Bone Marrow Transplant in a CD36-Negative Recipient.

William R. Broderick, MD, Amir A. Toor, MD, Brian R. Curtis, MS, Tulio E. Rodriguez, MD, Scott E. Smith, MD, PhD, Patrick J. Stiff, MD, Phillip J. DeChristopher, MD, PhD

Blood (2007) 110 (11): 4951.

https://doi.org/10.1182/blood.V110.11.4951.4951

Published: 2007

Journal Articles

Allogeneic Stem Cell Transplantation (SCT) Using Rabbit-ATG (Thymoglobulin®) and Low Dose Total Body Irradiation (TBI): Favorable Outcomes with Unrelated Donors (URD).

Amir A. Toor, MD, Tulio Rodriguez, MD, Najeeb Mohideen, MD, Scott E. Smith, MD, Mala Parthasarathy, BS, John Norton, MS, Jared Klein, MD, Patrick J. Stiff, MD

Blood (2005) 106 (11): 1767.

https://doi.org/10.1182/blood.V106.11.1767.1767

Published: 2005

Journal Articles

Final Report on Tandem Autologous Stem Cell Transplantation for Patients with Primary Progressive or Poor Risk Recurrent Hodgkin Lymphoma - A Two Institution Study.

Blood (2005) 106 (11): 2071.

https://doi.org/10.1182/blood.V106.11.2071.2071

Published: 2005

Journal Articles

Allogeneic Stem Cell Transplantation (SCT) Using Rabbit-ATG (Thymoglobulin®) and 2-Gy Total Body Irradiation (TBI): Reliable Early Engraftment with Minimal Acute Graft Vs. Host Disease (AGVHD).

Amir A. Toor, MD, Tulio Rodriguez, MD, Najeeb Mohideen, MD, Mala Parthasarathy, MS, Patrick J. Stiff, MD

Blood (2004) 104 (11): 2312.

https://doi.org/10.1182/blood.V104.11.2312.2312

Published: 2004

NARROW

Lymphocyte Recovery Kinetics in Patients Undergoing Myeloablative Conditioning and Allogeneic Stem Cell Transplantation

The Use of Biomarker Ferritin and Albumin As Well As HCT-CI, but Not PAM, Was Predictive of Suvival, Gvhd and, Relapse in Myeloid Malignancies

A Mathematical Model of Hematopoietic Stem Cell Transplantation and Analysis of the Effect of Drug Treatments on Transplantation in Patients with Lymphoma

Peptides Derived from the CMV Proteome Mimic Unique Stem Cell Transplant Recipient Specific Peptides: Possible Role in Eliciting a Pro-Gvh T Cell Response

Exome Sequencing Derived Alloreactivity Potential May Predict Gvhd in Allogeneic Stem Cell Transplantation

On The Organization Of Human T Cell Receptor Loci

Whole Exome Sequencing To Estimate Alloreactivity Potential Between Donors and Recipients In Stem Cell Transplantation

Favorable T Cell Reconstitution In Reduced Intensity Conditioned Allogeneic Stem Cell Transplantation with Low-Dose Rabbit Anti-Thymocyte Globulin and Total Body Irradiation

Immune Reconstitution In Anti-Thymocyte Globulin Conditioned Unrelated Donor Stem Cell Transplantation

Optimizing Outcomes in Multiple Myeloma Using Risk Stratified Allocation to Single Versus Tandem Autologous SCT.

Fractal Organization of the Human T Cell Repertoire in Health and Following Stem Cell Transplantation

Favorable Outcomes in Patients with High Donor-Derived T Cell Count Following In Vivo T Cell Depleted Reduced Intensity Allogeneic Stem Cell Transplantation

Adaptive Immunotherapy In Multiple Myeloma: Epigenetic Modification and Immunomodulation by Sequential Azacitidine and Lenalidomide to Generate Cancer Testis Antigen Specific Cellular Immune Response

Effectiveness of Reduced Toxicity Conditioning Regimen with Intravenous Busulfan Plus Pentostatin (BUPENT) in Patients Older Than 50 Years with Advanced Hematologic Malignancies.

Refractory Thrombocytopenia Due to Allo-Immune Anti-CD36 Complicating Unrelated Donor Bone Marrow Transplant in a CD36-Negative Recipient.

Allogeneic Stem Cell Transplantation (SCT) Using Rabbit-ATG (Thymoglobulin®) and Low Dose Total Body Irradiation (TBI): Favorable Outcomes with Unrelated Donors (URD).

Final Report on Tandem Autologous Stem Cell Transplantation for Patients with Primary Progressive or Poor Risk Recurrent Hodgkin Lymphoma - A Two Institution Study.

Allogeneic Stem Cell Transplantation (SCT) Using Rabbit-ATG (Thymoglobulin®) and 2-Gy Total Body Irradiation (TBI): Reliable Early Engraftment with Minimal Acute Graft Vs. Host Disease (AGVHD).

Email alerts

ASH Publications

American Society of Hematology

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only